Volume 121, Issue 9 pp. 1915-1919
Laryngology

Glucocorticoids regulate extracellular matrix metabolism in human vocal fold fibroblasts

Hang Zhou MD

Hang Zhou MD

Department of Otolaryngology, New York University, New York, New York

Search for more papers by this author
Mahalakshmi Sivasankar PhD

Mahalakshmi Sivasankar PhD

Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, Indiana

Search for more papers by this author
Dennis H. Kraus MD

Dennis H. Kraus MD

Head and Neck Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Search for more papers by this author
Vlad C. Sandulache MD, PhD

Vlad C. Sandulache MD, PhD

Bobby R. Alford Department of Otolaryngology–Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, U.S.A

Search for more papers by this author
Milan Amin MD

Milan Amin MD

Department of Otolaryngology, New York University, New York, New York

Search for more papers by this author
Ryan C. Branski PhD

Corresponding Author

Ryan C. Branski PhD

Department of Otolaryngology, New York University, New York, New York

Department of Otolaryngology, New York University School of Medicine, 550 First Avenue, 3C, New York, NY 10016Search for more papers by this author
First published: 16 August 2011
Citations: 28

Presented at the 2011 Combined Otolaryngology Spring Meetings (COSM), Chicago, Illinois, U.S.A., April 27–May 1, 2011.

This work was funded by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders (RO3 DC010267), Hackers for Hope, The Langeloth Foundation, and the Garban Fund. The authors have no other funding, financial relationships, or conflicts of interest to disclose.

Abstract

Objectives/Hypothesis:

Given the recent emergence of encouraging efficacy data regarding the utility of intralesional glucocorticoid (GC) injection for a variety of vocal fold pathologies, we sought to describe the location and expression pattern of the GC receptors within the vocal folds and quantify the effects of GCs on vocal fold fibroblasts.

Study Design:

In vitro, in vivo.

Methods:

Immunolocalization of the GC receptor was performed on normal rat vocal fold tissue. Receptor expression was also assayed in our human vocal fold fibroblast cell line. These cells were then treated with exogenous dexamethasone (DM) to quantify the effects of GCs on receptor expression, proliferation, transforming growth factor (TGF)-β–induced collagen secretion, and matrix protease synthesis.

Results:

Positive immunostaining for the GC receptor was found throughout the vocal fold with particularly strong staining in the epithelium and capillaries. Human vocal fold fibroblasts constitutively express the GC receptor, but this expression decreased in response to exogenous DM. DM also decreased fibroblast proliferation and TGF-β–induced collagen synthesis. DM also abrogated TGF-β–mediated effects on enzymes related extracellular matrix turnover.

Conclusions:

Our data are the first to provide mechanistic insight regarding the recently published favorable data regarding the utility of GCs in patients with vocal fold scar. Although further investigation is warranted, both the accessibility of this class of agents and the amenability to office-based procedures are likely to direct patient care models.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.